Dopamine transporter tryptophan mutants highlight candidate dopamine- and cocaine-selective domains

Molecular Pharmacology

Volumn 58, Issue 6, 2000, Pages 1581-1592

  Lin, Zhicheng ^a   Wang, Wenfei ^a   Uhl, George R ^a,b  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b Molecular Neurobiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; ALANINE; CHLORIDE ION; COCAINE; COCAINE DERIVATIVE; COMPLEMENTARY DNA; DOPAMINE; SODIUM ION; TRITIUM; TRYPTOPHAN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; COCAINE DEPENDENCE; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; GENE EXPRESSION; GENE MUTATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SHORT SURVEY; STRUCTURE ACTIVITY RELATION;

EID: 0033669731     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.6.1581     Document Type: Short Survey

References (37)

1. A mechanism of drug addiction revealed by structural study of enoyl reductase
2. Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium
3. Structural domains of catecholamine transperter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants
4. Aromatic-aromatic interactions in proteins
5. Cocaine receptor: Biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter
6. 50) of an enzymatic reaction
7. Human and mouse dopamine transporter genes: Conservation of 5'-flanking sequence elements and gene structures
8. Cation-π interactions in chemistry and biology: A new view of benzene, Phe, Tyr and Trp
9. A putative model of the dopamine transporter
10. Delineation of discrete domains for substrate cocaine and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters
11. Structure-activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenaline and dopaminergic neurones in rat brain homogenates
12. Characteristics of neuronal dopamine uptake
13. Dopamine transporter transmembrane domain polar mutants: ΔG and ΔΔG values implicate regions important for transporter functions
14. Probing structure of neurotransmitter transporters by substituted-cysteine accessibility method
15. Cloning and expression of a cocainesensitive rat dopamine transporter
16. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding
17. (-)-3β-substituted ecyonine methyl esters as inhibitors for cocaine binding and dopamine uptake
18. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition and expression
19. Dopamine transporter: Transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition
20. Effects of cocaine and repeated cocaine followed by withdrawal. Alterations of dopaminergic transporter turnover with no changes in kinetics of substrate recognition
21. Point mutations of the human dopamine transporter (hDAT) reveal differential binding of an amine and a non-amine ligand
22. The in situ size of the dopamine transporter is a tetramer as estimated by radiation inactivation
23. A multisubstrate kinetic mechanism of dopamine transport in the nucleus accumbens and its inhibition by cocaine
24. Dopamine fluctuations in the nucleus accumbens during maintenance, extinction and reinstatement of intravenous D-amphetamine self-administration
25. Is the short-latency dopamine response too short to signal reward error?
26. Cocaine-inhibition of ligand binding at dopamine, norepinephrine and seretonin transporters: A structure-activity study
27. Drug addiction: Bad habits add up
28. Mechanisms of biogenic amine neurotransmitter transporters
29. Functional multimerization of the seretonin transporter
30. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA
31. Neurotransmitter transporters: Three important gene families for neuronal function
32. Dopamine transporter mutations, small molecules and approaches to cocaine antagonist/dopamine transporter disinhibitor development
33. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic. TaqI RFLP
34. Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans
35. Relationship between subjective effects of cocaine and dopamine transporter occupancy
36. Dopamine transporter cysteine mutations: Second extracellular loop cysteines are required for transporter expression
37. Three-dimensional structure of the ion-coupled transport protein NhaA